GlaxoSmithKline and Pfizer will hold out for a better bid of at least £60 billion for their joint consumer healthcare venture, in opposition to an earlier offer they didn’t like, Financial Times writes. They’re rejecting a £50 billion offer from Unilever, which GSK said was...
In today’s top news, Venmo is adding transaction charges for goods and services, and U.S. credit card companies are looking to encourage consumers to borrow. And GlaxoSmithKline is planning to take its consumer health division in a spinoff listing. Venmo Raises P2P Fees, To Charge...
Goldman Sachs and Citi are working with GlaxoSmithKline on a new listing for a spinoff of its consumer unit, Bloomberg writes. The companies will also help with Glaxo’s defense against the possibility of an activist campaign from Elliot Investment Management, which is helmed by billionaire...
India is increasingly a hotbed for commerce, and that trend continues with Nestle, Unilever and Coca-Cola reportedly each bidding for GlaxoSmithKline’s nutritional business, Horlicks of India. According to Reuters, Horlicks will cost more than $4 billion and “initial bids were due on Monday and the...
April 27, 2022
GlaxoSmithKline (GSK) is getting ready to launch its consumer health spinoff with Pfizer this summer, the company said in its first-quarter earnings report Wednesday (April 27). The company first announced plans for the division — now dubbed “Haleon” — last year. The drugmaker’s consumer unit makes products such as Aquafresh toothpaste. See more: GlaxoSmithKline Plans […]
January 16, 2022
GlaxoSmithKline and Pfizer will hold out for a better bid of at least £60 billion for their joint consumer healthcare venture, in opposition to an earlier offer they didn’t like,...
June 27, 2021
Goldman Sachs and Citi are working with GlaxoSmithKline on a new listing for a spinoff of its consumer unit, Bloomberg writes. The companies will also help with Glaxo’s defense against...
September 19, 2018
India is increasingly a hotbed for commerce, and that trend continues with Nestle, Unilever and Coca-Cola reportedly each bidding for GlaxoSmithKline’s nutritional business, Horlicks of India. According to Reuters, Horlicks...
